Q3 2018 Holdings
Filed 2018-11-14 | 103 holdings | $357.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $52.7M | 6,910,789 | 14.7% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $50.1M | 1,424,571 | 14.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $49.8M | 656,500 | 13.9% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $46.3M | 4,707,912 | 12.9% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $44.9M | 3,093,416 | 12.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $26.9M | 348,200 | 7.5% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $22.7M | 320,000 | 6.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $20.8M | 1,233,734 | 5.8% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $15.2M | 3,491,922 | 4.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $13.5M | 729,948 | 3.8% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $7.7M | 250,000 | 2.1% |
| Addus Homecare Corp(ADUS) | COM | 006739106 | $4.6M | 65,590 | 1.3% |
| Horizon Pharma PLC | SHS | G4617B105 | $129.4K | 6,609,894 | 0.0% |
| Homology Medicines Inc | COM | 438083107 | $119.5K | 5,227,035 | 0.0% |
| Horizon Pharma Invt LTD | NOTE 2.500% 3/1 | 44052TAB7 | $99.5K | $99,100,000 | 0.0% |
| Nevro Corp | NOTE 1.750% 6/0 | 64157FAA1 | $99.4K | $100,000,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $94.8K | 1,540,448 | 0.0% |
| Dexcom Inc | NOTE 0.750% 5/1 | 252131AF4 | $84.2K | $55,000,000 | 0.0% |
| Mylan N V | SHS EURO | N59465109 | $67.4K | 1,842,111 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $65.4K | 2,455,586 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $65.1K | 2,900,000 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $64.6K | 647,466 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $64.0K | 1,117,651 | 0.0% |
| Endocyte Inc | COM | 29269A102 | $62.4K | 3,514,084 | 0.0% |
| Intersect ENT Inc | COM | 46071F103 | $61.8K | 2,147,950 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $59.8K | 917,000 | 0.0% |
| Kempharm Inc | NOTE 5.500% 2/0 | 488445AB3 | $48.3K | $75,000,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $47.8K | 296,000 | 0.0% |
| Wright MED Group N V | NOTE 2.250%11/1 | 98236JAB4 | $45.6K | $31,500,000 | 0.0% |
| CVS Health Corp(CVS)Call | COM | 126650100 | $44.6K | 566,800 | 0.0% |
| Xeris Pharmaceuticals Inc | COM | 98422L107 | $43.9K | 2,498,666 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $41.0K | 525,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $39.6K | 840,911 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $37.0K | 569,356 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $36.9K | 1,158,841 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $36.2K | $36,000,000 | 0.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $35.5K | 245,000 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $34.7K | 1,227,061 | 0.0% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $33.5K | 262,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $33.1K | 1,590,000 | 0.0% |
| K2m Group Hldgs Inc | NOTE 4.125% 8/1 | 48273JAB3 | $30.1K | $20,000,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $29.9K | 525,040 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $29.2K | 260,064 | 0.0% |
| Select MED Hldgs Corp(SEM) | COM | 81619Q105 | $28.1K | 1,526,000 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $27.1K | 1,061,956 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $26.0K | 95,000 | 0.0% |
| DFB Healthcare Acquistion Co | UNIT 01/30/2023 | 23291E208 | $25.5K | 2,500,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $24.0K | 294,000 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $22.9K | 1,617,730 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $20.8K | 275,000 | 0.0% |